Cargando…
Entecavir-associated thrombocytopenia
Entecavir (ETV) is widely used in the treatment of hepatitis B, but there are only a few reports about entecavir-associated thrombocytopenia, and it is considered as an immediate response and inappropriate to continue the treatment with other nucleoside analogues. Now, we report the third case, and...
Autores principales: | Yu, Yi, Feng, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674478/ https://www.ncbi.nlm.nih.gov/pubmed/34823407 http://dx.doi.org/10.1177/20587384211059676 |
Ejemplares similares
-
Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia
por: Yohannan, Binoy, et al.
Publicado: (2019) -
Entecavir-Associated Thrombocytopenia in a Decompensated Cirrhotic Patient: A Case Report and Literature Review
por: Fan, Xiaoli, et al.
Publicado: (2016) -
Entecavir: Mitochondrial myopathy: case report
Publicado: (2022) -
Severe Acute Hepatitis B Treated With Entecavir.
por: De Socio, Giuseppe Vittorio Luigi, et al.
Publicado: (2011) -
A Granulomatous Drug Eruption Induced by Entecavir
por: Yoon, Jimi, et al.
Publicado: (2013)